Kirsten Schmitt
Medical · Traverse City, MINPI 1528121811
Payments from drug & device makers
Across 505 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Amgen$1K
- Sanofi$709
- Takeda Pharmaceuticals U.S.A., Inc.$501
- Regeneron Healthcare Solutions, Inc.$436
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 100 | $2,177 |
| GSK | 112 | $1,606 |
| Amgen(2 entities) | 52 | $1,023 |
| Sanofi | 26 | $709 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $501 |
| Regeneron Healthcare Solutions, Inc. | 18 | $436 |
| Novartis | 18 | $426 |
| Genentech USA, Inc. | 24 | $405 |
| AbbVie | 16 | $397 |
| CSL Behring | 19 | $393 |
| Pfizer | 23 | $345 |
| Pharming Healthcare, Inc. | 7 | $246 |
| Aimmune Therapeutics, Inc. | 4 | $189 |
| Boehringer Ingelheim | 7 | $159 |
| Grifols USA, LLC | 6 | $140 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $127 |
| Kaleo, Inc. | 6 | $109 |
| Organon | 4 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $101 |
| Biocryst US Sales Co., LLC | 4 | $89 |
| Ionis Pharmaceuticals, Inc. | 2 | $65 |
| LEO Pharma Inc. | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 4 | $60 |
| Welch Allyn | 1 | $58 |
| Alk-abello, Inc | 2 | $46 |
| Blueprint Medicines Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Verona Pharma, Inc. | 1 | $20 |
| Dermavant Sciences, Inc. | 1 | $20 |
| Greer Laboratories, Inc. | 1 | $19 |
| Insmed, Inc. | 1 | $19 |
| Incyte Corporation | 1 | $19 |
| Merck | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Hospira, Inc. | 1 | $14 |
How this compares
$10,166 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Traverse City
- Jesse KogelmanTraverse City$21K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.